Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Acetaminophen Use During Pregnancy

Safety Profile and Recommendations

  • The Society for Maternal-Fetal Medicine (SMFM) advises that acetaminophen be considered a reasonable and appropriate medication choice for the treatment of pain and/or fever during pregnancy, and should be used at the lowest effective dose for the shortest possible duration 1, 2
  • Acetaminophen is the most widely used medication during pregnancy, with 40-65% of pregnant women using it at some point, primarily for headache and fever 3
  • Acetaminophen crosses the placenta relatively easily and has been detected in umbilical cord blood after maternal administration 3

Evidence on Potential Risks

  • Recent observational studies have suggested associations between prenatal acetaminophen exposure and neurodevelopmental outcomes in children, including increased risk of ADHD symptoms (12.2-25% increased risk) and autism spectrum disorder (12.9% increased risk) 4
  • Several systematic reviews have found associations between prenatal acetaminophen exposure and neurodevelopmental disorders, including a 20-30% increased risk of ADHD and ASD outcomes 5

Limitations of Current Evidence

  • The FDA and SMFM have evaluated these studies and determined that "the weight of evidence is inconclusive regarding a possible causal relationship between acetaminophen use and neurobehavioral disorders in the offspring" 1, 2
  • Most studies have significant methodological and design limitations, including inability to determine or control for all potential confounders, recall bias, and failure to adjust for multiple testing 1, 2

Clinical Guidance for Healthcare Providers

  • Acetaminophen should be used during pregnancy only when medically necessary, at the lowest effective dose for the shortest possible duration, and avoiding excessive or prolonged use 6, 7
  • Communication regarding the risks versus the benefits of acetaminophen use should occur between patient and provider 1, 2
  • Pregnant women who use acetaminophen should be closely monitored across all trimesters of pregnancy 6

Safety of IV Paracetamol During Pregnancy

Introduction to Paracetamol Use

  • Paracetamol is considered the analgesic of choice for the treatment of mild to moderate pain during any stage of pregnancy, according to the Annals of Oncology 8, 9

Advantages of IV Administration

  • Unlike NSAIDs, paracetamol does not cause premature closure of the fetal ductus arteriosus or oligohydramnios, as noted by the Annals of Oncology 8, 9

Special Considerations for Surgery During Pregnancy

  • Paracetamol is an essential component of multimodal analgesia for pregnant women undergoing surgery, as stated by the Annals of Oncology 8, 9
  • Adequate pain relief with paracetamol is essential postoperatively to prevent reactive preterm contractions, according to the Annals of Oncology 8, 9
  • If paracetamol alone is inadequate for pain control, short-term narcotic use is also considered safe during pregnancy, as noted by the Annals of Oncology 8, 9
  • NSAIDs should be avoided, particularly after 28 weeks of gestation, due to risks of premature closure of the fetal ductus arteriosus, as stated by the Annals of Oncology 8, 9

Acetaminophen Use and Neurodevelopmental Risks

Evidence on Neurodevelopmental Effects

  • Multiple systematic reviews found associations between prenatal acetaminophen exposure and increased risk of ADHD (12-30% increased risk) and autism spectrum disorder (13-19% increased risk), with the risk appearing dose-dependent, particularly for exposure ≥28 days 10
  • The risk of neurodevelopmental outcomes may be higher with third trimester exposure, and male offspring may have slightly higher risk than females, though effect sizes are small 10

Clinical Considerations

  • For specific conditions, such as migraine, acetaminophen is recommended as first-line treatment despite poor efficacy, and for post-vaginal delivery, a dose of 650-975mg every 6-8 hours is suggested 10